
News|Articles|December 19, 2023
- MHE December 2023
- Volume 33
- Issue 12
State of the Industry: Key Issues, Technology Impact, Presidential Campaign Focus, and Challenges Ahead in 2024
We conducted our annual State of the Industry survey in the early part of November 2023. The survey had 432 respondents, of whom 56% self-reported working for a payer organization (pharmacy benefit manager, insurer or self-insured employer), 34% for a provider organization and the remainder for government or an unspecified “other” category.
Advertisement
Articles in this issue
over 2 years ago
The Best Hope for Eradicating HCVover 2 years ago
Biosimilars are Ascendantover 4 years ago
ICER: More Transparency of Drug Coverage Policies NeededAdvertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Key Takeaways, Study Limitations, and the Broader Implications of CROWN for Patients, Providers, and Payers
2
FDA approves Lumvoa, first TED therapy labeled for both active and chronic disease
3
The experience gap in healthcare starts with an identity gap
4
The MASLD-breast cancer connection
5































